Please select an option below to help us tailor your newsletter to best suit your content interests!
“We really believe that biosimilars line up as a value accretion for every constituency, whether it’s the patient, the practice, or the payer,” said Lee Schwartzberg, MD, FACP, executive director, West Cancer Center. Click here for full article & video interview. Transcript: OneOncology announced that its practices have begun administering the 2 cancer… Read more »
West Cancer Center is the first center in the country to offer the first FDA-approved Mesothelioma treatment in more than 15 years A clinical study showed that the NovoTTF-100L™ System in combination with chemotherapy may help people with malignant pleural mesothelioma extend their lives West Cancer Center is pleased to announce they have been… Read more »
Maggie Spence said that when her mother, Dorchelle, was diagnosed with breast cancer two years ago, it took awhile for her to gather the strength to attend chemotherapy sessions with her. “I couldn’t stand the thought of seeing her in a weaker position than me,” Maggie, 16, admitted. But when the Lausanne Collegiate School student… Read more »
In 2016, I was diagnosed with Stage 1 breast cancer. And I was, on one level, lucky. Lucky that, after not bothering to get a mammogram since 2011, I didn’t discover a tumor that had spread to other parts of my body. “After four years of not being screened, that is a blessing,” said Keesha… Read more »
Even with aggressive and skilled treatment, pancreatic cancer is often deadly. But, work by West Cancer Center’s Dr. Axel Grothey — in partnership with doctors at the Mayo Clinic — shows that a new treatment protocol offers better outcomes for patients with the disease. Research published in the Annals of Surgery details an approach used… Read more »
Patients with relapsed or refractory non-Hodgkin’s lymphoma and young adults with relapsed or refractory acute lymphoblastic leukemia now have access to a procedure called chimeric antigen receptor T-cell therapy, abbreviated as CAR-T. A collaboration between the physicians at the UTHSC Blood and Marrow Transplant Center and the clinical research team at West Cancer Center, supported… Read more »
The FDA has approved a new cancer treatment that is being used in the Bluff City. Doctors are convinced it could even cure some forms of cancer. This new cancer treatment is being called a game-changer. Doctors are now able to use a patient’s own immune system to attack cancers. In the heart of the… Read more »
Join WCC Registered Dietitian Nutritionist, Anita Vincent, on Tuesdays and Thursdays at our Wolf River campus at 12pm a free nutrition workshop open to all patients, their loved ones, and staff! Sessions are listed below: Tuesday, Jan 8: Nutrition 101 – Back to Basics Thursday, Jan 24: Herbs & Supplements – Garlic Tuesday, Feb. 12:… Read more »
Heather Greene, a nurse practitioner at West Cancer Center, discusses common treatment-related toxicities in metastatic renal cell carcinoma (RCC). In terms of anti-VEGF tyrosine kinase inhibitors (TKIs), healthcare providers should be aware of potential diarrhea, hypertension, palmar-plantar erythrodysesthesia, as well as skin and hair depigmentation, says Greene. Patients who are receiving mTOR inhibitors should be… Read more »
Bradley G. Somer, MD, associate professor of hematology/oncology, head of strategic expansion/development, University of Tennessee West Cancer Center, discusses the potential for immunotherapy combinations in patients with metastatic renal cell carcinoma (mRCC). In the CheckMate-214 study, the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) showed a clear survival advantage over the frontline standard-of-care sunitinib (Sutent)… Read more »